Perida, Roger .
HRN: 11-81-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/13/2024
08/19/2024
IV
600mg
Q6 X7days
Fracture Closed Comminuted Middle Third Radius, Left Secondary To Fall
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes